Foresite Capital Management IV, LLC

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Foresite Capital Management IV, LLC reported 8 stock positions worth $237.1 million. Its top holding was Pharvaris (PHVS) at 56.9% of the portfolio, followed by Cytokinetics (CYTK, 14.0%) and Eikon Therapeutics (EIKN, 8.7%). Compared with Q4 2025, it opened 1 new position, added to 1 and reduced 1. The biggest buy was a new position in Eikon Therapeutics (EIKN) and the biggest sale Maze Therapeutics (MAZE, shares −70%).

Most Recent 13F
Q2 2026
Location
WEST HOLLYWOOD, CA
CIK
0001704132
Portfolio Value
$237.1M (Q1 2026)
SEC Filing
0001104659-26-062462 ↗ filed May 15, 2026

Holdings Value

0$100.0M$200.0M$300.0M Q1 2024: $197.9M Q1 2024 Q2 2024: $148.8M Q2 2024 Q3 2024: $153.0M Q3 2024 Q4 2024: $108.8M Q4 2024 Q1 2025: $111.1M Q1 2025 Q2 2025: $123.8M Q2 2025 Q3 2025: $182.6M Q3 2025 Q4 2025: $229.7M Q4 2025 Q1 2026: $237.1M $237.1M Q1 2026 Q2 2026: $290.2M Q2 2026

Holdings 8 stocks · $237.1M

PHVS Pharvaris NV 56.94% 4,778,581 $135.0M No change
CYTK Cytokinetics Inc. 13.99% 503,295 $33.2M Add +9.8%
EIKN Eikon Therapeutics Inc. 8.67% 1,943,682 $20.6M New
LYEL Lyell Immunopharma Inc. 6.77% 800,399 $16.1M No change
RLAY Relay Therapeutics Inc. 4.20% 1,000,000 $9.9M No change
XENE Xenon Pharmaceuticals Inc. 3.92% 160,000 $9.3M No change
ALEC Alector Inc. 3.53% 3,887,200 $8.4M No change
MAZE Maze Therapeutics Inc. 1.98% 156,901 $4.7M Reduce -70.0%

Portfolio Sells Q4 2025 → Q1 2026

MAZE Maze Therapeutics Inc. Reduce -70.0% 1.98% −7.45

Portfolio Buys Q4 2025 → Q1 2026

EIKN Eikon Therapeutics Inc. New 8.67% +8.67
CYTK Cytokinetics Inc. Add +9.8% 13.99% +1.31

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 6$290.2MPHVS, CYTK, EIKN, RLAY, XENE
Q1 2026 8$237.1MPHVS, CYTK, EIKN, LYEL, RLAY
Q4 2025 7$229.7MPHVS, CYTK, LYEL, MAZE, RLAY
Q3 2025 6$182.6MPHVS, CYTK, MAZE, LYEL, XENE
Q2 2025 6$123.8MPHVS, MAZE, LYEL, XENE, KURA
Q1 2025 5$111.1MPHVS, MAZE, LYEL, KURA, RLAY
Q4 2024 4$108.8MPHVS, KURA, LYEL, RLAY
Q3 2024 5$153.0MPHVS, KURA, SNDX, LYEL, RLAY
Q2 2024 4$148.8MPHVS, KURA, SNDX, LYEL
Q1 2024 5$197.9MPHVS, KURA, KNTE, SNDX, LYEL